Koujunkai Daido Clinic

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• COPD1 trial
• Obstructive sleep apnoea1 trial
• Peripheral artery disease1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial

Status

• Recruiting3 trials
• Completed1 trial

Lead sponsor

• Eli Lilly and Company3 trials
• Pfizer1 trial

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  NCT07363694· Phase 2/3· Pfizer· Source

• Recruiting

  Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

  NCT07223593· Phase 3· Eli Lilly and Company· Source

  Contact: Sumio Morita (principal investigator)

• Recruiting

  A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

  NCT07202884· Phase 3· Eli Lilly and Company· Source

  Contact: Hiroyuki Kamiya (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting
• Obesity1 recruiting
• Peripheral artery disease1 recruiting

Closed trials

• Completed

  Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

  NCT05412004· Phase 3· Eli Lilly and Company· Source